129 related articles for article (PubMed ID: 3182107)
1. Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma.
Oosterwijk E; Warnaar SO; Zwartendijk J; van der Velde EA; Fleuren GJ; Cornelisse CJ
Int J Cancer; 1988 Nov; 42(5):703-8. PubMed ID: 3182107
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
4. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma.
Al-Abadi H; Nagel R
Eur Urol; 1988; 15(3-4):271-6. PubMed ID: 3215262
[TBL] [Abstract][Full Text] [Related]
6. Ploidy and prognosis in renal carcinoma.
Lanigan D; McLean PA; Murphy DM; Donovan MG; Curran B; Leader M
Br J Urol; 1993 Jan; 71(1):21-4. PubMed ID: 8435731
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
9. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.
Basting R; Corvin S; Händel D; Hinke A; Schmidt D
Anticancer Res; 1999; 19(2C):1493-5. PubMed ID: 10365130
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of DNA ploidy in small renal cell carcinoma.
Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
[TBL] [Abstract][Full Text] [Related]
15. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma.
Lanigan DJ; McLean PA; Murphy DM; Donovan MG; Leader M
Eur Urol; 1992; 22(3):228-34. PubMed ID: 1468480
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma.
Chin JL; Pontes JE; Frankfurt OS
J Urol; 1985 Apr; 133(4):582-5. PubMed ID: 3981703
[TBL] [Abstract][Full Text] [Related]
17. A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
Büscheck F; Fraune C; Kluth M; Lennartz M; Simon R; Hube-Magg C; Morlock C; Barbieri S; Wahl C; Eichelberg C; Möller-Koop C; Höflmayer D; Wittmer C; Wilczak W; Sauter G; Fisch M; Eichenauer T; Rink M
World J Urol; 2021 Mar; 39(3):829-837. PubMed ID: 32361874
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
19. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
